Author
Listed:
- Daniel Bodden
- Ralf-Dieter Hilgers
- Franz König
Abstract
Background: Group sequential designs, which allow early stopping for efficacy or futility, may benefit from balanced sample sizes at interim and final analyses. This requirement for balance limits the choice of admissible randomization procedures. We investigate if the choice of randomization procedure, whether balanced or not, impacts the type I error probability and power in small sample clinical trials with group sequential designs.Methods: We start with a literature review to assess how randomization procedures are reported in group sequential trials. We then investigate the impact of randomization procedures on the type I error probability and power of trials with Pocock, O’Brien-Fleming, Lan-DeMets and inverse normal combination test designs.Results: Our findings show that only a limited number of published group sequential trials report sufficient randomization details. Simulation results demonstrate that deficiencies in the implementation of randomization can inflate type I error rates. Some combinations of group sequential designs and randomization procedures cause a loss of power, for example, when using inverse normal combination tests. When the planned balanced allocation ratio in (interim) analyses cannot be ensured, the Lan-DeMets approach is preferable for small sample trials due to its robustness to deviations between the planned and observed allocation ratio. The inverse normal combination test, while useful in trials with limited prior information, should be used cautiously with permuted block randomization that maintains the planned allocation ratio to avoid power loss.Conclusion: We propose a framework for selecting the most suitable combinations of group sequential design and randomization procedure for small sample clinical trials. Our findings highlight the need for improved reporting of randomization methods in group sequential clinical trials. Further, the validity of some of the group sequential designs relies on the application of appropriate randomization procedures which were difficult to identify in the literature and is possibly violated.
Suggested Citation
Daniel Bodden & Ralf-Dieter Hilgers & Franz König, 2025.
"Randomization in clinical trials with small sample sizes using group sequential designs,"
PLOS ONE, Public Library of Science, vol. 20(6), pages 1-26, June.
Handle:
RePEc:plo:pone00:0325333
DOI: 10.1371/journal.pone.0325333
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pone00:0325333. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: plosone (email available below). General contact details of provider: https://journals.plos.org/plosone/ .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.